Crizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey

dc.authoridPaydas, Semra/0000-0003-4642-3693
dc.authoridYaşar, Hatime Arzu/0000-0002-0545-1383
dc.authoridUysal, Mukremin/0000-0002-8524-0665
dc.authoridKilickap, Saadettin/0000-0003-1637-7390
dc.authoridCicin, Irfan/0000-0002-7584-3868
dc.authoridEralp, Yesim/0000-0001-9603-4755;
dc.authorwosidPaydas, Semra/F-3132-2018
dc.authorwosidUrvay, Semiha/AAM-2335-2021
dc.authorwosidTURHAL, NAZIM SERDAR/AAJ-4421-2020
dc.authorwosidKucukoner, Mehmet/E-1162-2013
dc.authorwosidSendur, Mehmet Ali Nahit/H-7555-2014
dc.authorwosidYaşar, Hatime Arzu/HGC-5631-2022
dc.authorwosidUysal, Mukremin/B-8956-2014
dc.contributor.authorKilickap, S.
dc.contributor.authorOzturk, A.
dc.contributor.authorKaradurmus, N.
dc.contributor.authorKorkmaz, T.
dc.contributor.authorYumuk, P.
dc.contributor.authorCicin, I.
dc.contributor.authorPaydas, S.
dc.date.accessioned2024-06-12T11:09:27Z
dc.date.available2024-06-12T11:09:27Z
dc.date.issued2018
dc.departmentTrakya Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.endpageS478en_US
dc.identifier.issn1556-0864
dc.identifier.issn1556-1380
dc.identifier.issue10en_US
dc.identifier.startpageS477en_US
dc.identifier.urihttps://hdl.handle.net/20.500.14551/22795
dc.identifier.volume13en_US
dc.identifier.wosWOS:000454014501235en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherElsevier Science Incen_US
dc.relation.ispartofJournal Of Thoracic Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectNSCLCen_US
dc.subjectALK Inhibitoren_US
dc.subjectCrizotiniben_US
dc.titleCrizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkeyen_US
dc.typeConference Objecten_US

Dosyalar